Factors contributing to the new coronavirus infection, increased risk of complications and death from it in the armed forces of the Russian Federation

Abstract

Based on the assessment of factors that contribute to a new coronavirus infection, the risk of complications, mortality, and lethality from it in the Armed Forces of the Russian Federation were analyzed. A detailed timeline of the development of the coronavirus pandemic in the Russian Federation has been demonstrated, showing indicators of peak and overall morbidity and mortality and prevailing strains of a new coronavirus infection, depending on the waves of the pandemic. The study evaluated the features of the course of a new coronavirus infection in the Eurasian region using data from the international register “Analysis of the dynamics of comorbid diseases in patients infected with severe acute respiratory syndrome-2 coronavirus”. Modern ideas about the main pathogenetic mechanisms of involvement of the circulatory system, which underlie the development of a severe course, mortality, and lethal outcomes, are outlined. The study also presented the concept of metabolic and hemodynamic insufficiency, which justifies the inability of the desynchronized circulatory system and systems of vascular homeostasis and hemostasis to restore the previous level of functioning after a new coronavirus infection. The possibilities of carrying out differentiated anti-epidemiological measures, including the use of information technologies, aimed at reducing the spread of a new coronavirus infection, were evaluated. The mortality and mortality from a new coronavirus infection in the Armed Forces of the Russian Federation, including the effect of a new coronavirus infection on an increase in the incidence of non-communicable diseases in military personnel of different age groups, were presented. The study also considered issues of the need to introduce a rehabilitation strategy to correct conditions that occur after a new coronavirus infection, reduce the risk of subsequent mortality and lethality, and reduce it in the long term.

Keywords

new coronavirus infection / cardiovascular diseases / mortality / mortality / peak incidence / peak mortality / strains of a new coronavirus infection / international register / vascular homeostasis

References

[1] Magro C, Mulvey JJ, Berlin D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five. Transl Res. 2020;220:1–13. DOI: 10.1016/j.trsl.2020.04.007

[2] Magro C., Mulvey J.J., Berlin D., et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five // Transl Res. 2020. Vol. 220. P. 1–13. DOI: 10.1016/j.trsl.2020.04.007

[3] Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583–59. DOI: 10.1038/s41591-022-01689-3

[4] Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19 // Nat Med. 2022. Vol. 28, No. 3. P. 583–59. DOI: 10.1038/s41591-022-01689-3

[5] Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430–436. DOI: 10.1038/s41586-020-2521-4

[6] Williamson E.J., Walker A.J., Bhaskaran K., et al. Factors associated with COVID-19-related death using OpenSAFELY // Nature. 2020. Vol. 584, No. 7821. P. 430–436. DOI: 10.1038/s41586-020-2521-4

[7] Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. DOI: 10.1001/jama.2020.2648

[8] Wu Z., McGoogan J.M. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention // JAMA. 2020. Vol. 323, No. 13. P. 1239–1242. DOI: 10.1001/jama.2020.2648

[9] COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet. 2022;399(10344):2351–2380. DOI: 10.1016/S0140-6736(22)00484-6

[10] COVID-19 Cumulative Infection Collaborators. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis // Lancet. 2022. Vol. 399, No. 10344. P. 2351–2380. DOI: 10.1016/S0140-6736(22)00484-6

[11] Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19. Russian Journal of Cardiology. 2021;26(4):116–131. (In Russ.). DOI: 10.15829/1560-4071-2021-4470

[12] Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г., и др. Международный регистр «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2» (Aктив SARS-CoV-2): анализ предикторов неблагоприятных исходов острой стадии новой коронавирусной инфекции // Российский кардиологический журнал. 2021. Т. 26, № 4. С. 116–131. DOI: 10.15829/1560-4071-2021-4470

[13] Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. Clinical features of post-COVID-19 period. Results of the international register “Dynamic analysis of comorbidities in SARS-CoV-2 survivors (AKTIV SARS-CoV-2)”. Data from 6-month follow-up. Russian Journal of Cardiology. 2021;26(10):86–98. (In Russ.). DOI: 10.15829/1560-4071-2021-4708

[14] Арутюнов Г.П., Тарловская Е.И., Арутюнов А.Г., и др. Клинические особенности постковидного периода. Результаты международного регистра «Анализ динамики коморбидных заболеваний у пациентов, перенесших инфицирование SARS-CoV-2 (Актив SARS-CoV-2)». Предварительные данные (6 месяцев наблюдения) // Российский кардиологический журнал. 2021. Т. 26, № 10. С. 86–98. DOI: 10.15829/1560-4071-2021-4708

[15] Fisun AY, Cherkashin DV, Tyrenko VV, et al. Role of renin-angiotensin-aldosterone system in the interaction with coronavirus SARS-CoV-2 and in the development of strategies for prevention and treatment of new coronavirus infection (COVID-19). Arterial Hypertension. 2020;26(3):248–262. (In Russ.). DOI: 10.18705/1607-419X-2020-26-3-248-262

[16] Фисун А.Я., Черкашин Д.В., Тыренко В.В., и др. Роль ренин-ангиотензин-альдостероновой системы во взаимодействии с коронавирусом SARS-CoV-2 и в развитии стратегий профилактики и лечения новой коронавирусной инфекции (COVID-19) // Артериальная гипертензия. 2020. Т. 26, № 3. С. 248–262. DOI: 10.18705/1607-419X-2020-26-3-248-262

[17] Cherkashin DV. “Bonded by one chain, related to one purpose”: what is primary in the development of thrombotic complications in COVID-19 — mechanisms of inflammation or endothelium damage? Russian Military Medical Academy Reports. 2021;40(3):45–49. (In Russ.). DOI: 10.17816/rmmar76904

[18] Черкашин Д.В. «Скованные одной цепью, связанные одной целью»: что является первичным в развитии тромботических осложнений при COVID-19 — механизмы воспаления или повреждение эндотелия? // Известия Российской военно-медицинской академии. 2021. Т. 40, № 3. С. 45–49. DOI: 10.17816/rmmar76904

[19] Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology. 2020;5(7):811–818. DOI: 10.1001/jamacardio.2020.1017

[20] Guo T., Fan Y., Chen M., et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) // JAMA Cardiology. 2020. Vol. 5, No. 7. P. 811–818. DOI: 10.1001/jamacardio.2020.1017

[21] М Maev IV, Shpektor AV, Vasilyeva EY, et al. Novel coronavirus infection COVID-19: extrapulmonary manifestations. Therapeutic archive. 2020;92(8):4–11. (In Russ.). DOI: 10.26442/00403660.2020.08.000767

[22] Маев И.В., Шпектор А.В., Васильева Е.Ю., и др. Новая коронавирусная инфекция COVID-19: экстрапульмональные проявления // Терапевтический архив. 2020. Т. 92, № 8. С. 4–11. DOI: 10.26442/00403660.2020.08.000767

[23] Kryukov EV, Cherkashin DV, Reutskiy IA, et al. Differentiated approach to the implementation of preventive and anti-epidemic measures among military personnel based on the COVID-19 disease risk assessment scale. Infectious Diseases: News, Opinions, Training. 2021;10(2):31–38. (In Russ.). DOI: 10.33029/2305-3496-2021-10-2-31-38

[24] Крюков Е.В., Черкашин Д.В., Реутский И.А., и др. Дифференцированный подход к проведению профилактических и противоэпидемических мероприятий среди военнослужащих на основе шкалы оценки рисков заболевания COVID-19 // Инфекционные болезни: новости, мнения, обучение. 2021. Т. 10, № 2. С. 31–38. DOI: 10.33029/2305-3496-2021-10-2-31-38

[25] Zagorodnikov GG, Uliukin IM, Orlova ES, et al. Justification of the tasks of the register of military personnel, affected by SARS-CoV-2. Bulletin of the Russian Military Medical Academy. 2020;22(3): 153–158. (In Russ.). DOI: 10.17816/brmma50552

[26] Загородников Г.Г., Улюкин И.М., Орлова Е.С., и др. Обоснование задач регистра военнослужащих, инфицированных SARS-CoV-2 // Вестник Российской военно-медицинской академии. 2020. Т. 22, № 3. С. 153–158. DOI: 10.17816/brmma50552

[27] Kryukov EV, Trishkin DV, Salukhov VV, Ivchenko EV. Opyt voennoi meditsiny v bor’be s novoi koronavirusnoi infektsiei. Vestnik Rossijskoj Akademii Nauk. 2022;92(7):699–706. (In Russ.).

[28] Крюков Е.В., Тришкин Д.В., Салухов В.В., Ивченко Е.В. Опыт военной медицины в борьбе с новой коронавирусной инфекцией // Вестник Российской академии наук. 2022. Т. 92, № 7. С. 699–706.

[29] Gorenchuk AN, Zhogolev SD, Kuzin AA, et al. Analysis of the incidence of COVID-19 in organized military collectives of various types. Bulletin of the Russian Military Medical Academy. 2022;24(2):289–297. (In Russ.). DOI: 10.17816/brmma106464

[30] Горенчук А.Н., Жоголев С.Д., Кузин А.А., и др. Анализ заболеваемости COVID-19 в организованных воинских коллективах разного типа // Вестник Российской военно-медицинской академии. 2022. Т. 24, № 2. С. 289–297. DOI: 10.17816/brmma106464

[31] Ivchenko EV, Kotiv BN, Ovchinnikov DV, Bucenko SA. Results of the work of the Military medical academy research institute of novel coronavirus infection problems through 2020–2021. Bulletin of the Russian Military Medical Academy. 2021;23(4):93–104. (In Russ.). DOI: 10.17816/brmma83094

[32] Ивченко Е.В., Котив Б.Н., Овчинников Д.В., Буценко С.А. Результаты работы научно-исследовательского института проблем новой коронавирусной инфекции Военно-медицинской академии за 2020–2021 гг. // Вестник Российской военно-медицинской академии. 2021. Т. 23, № 4. C. 93–104. DOI: 10.17816/brmma83094

[33] Schett G, Manger B, Simon D, Caporali R. COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol. 2020;16(8):465–470. DOI: 10.1038/s41584-020-0451-z

[34] Schett G., Manger B., Simon D., Caporali R. COVID-19 revisiting inflammatory pathways of arthritis // Nat Rev Rheumatol. 2020. Vol. 16, No. 8. P. 465–470. DOI: 10.1038/s41584-020-0451-z

[35] Maksoud R, Balinas C, Holden S, et al. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. 2021;19(1):81. DOI: 10.1186/s12967-021-02742-4

[36] Maksoud R., Balinas C., Holden S., et al. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome // J Transl Med. 2021. Vol. 19, No. 1. ID 81. DOI: 10.1186/s12967-021-02742-4

[37] Wang X, Zhou Y, Jiang N, et al. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved. Int Soc Infect Dis. 2020;95:433–435. DOI: 10.1016/j.ijid.2020.04.063

[38] Wang X., Zhou Y., Jiang N., et al. Persistence of intestinal SARS-CoV-2 infection in patients with COVID-19 leads to re-admission after pneumonia resolved // Int Soc Infect Dis. 2020. Vol. 95. P. 433–435. DOI: 10.1016/j.ijid.2020.04.063

[39] Glöckl R, Boer-Schinner H, Kochulla AR, et al. Recommendations from the German Respiratory Society for Pulmonary Rehabilitation in Patients with COVID-19. Pneumologie. 2020;74(8):496–504. DOI: 10.1055/a-1193-9315

[40] Glöckl R., Boer-Schinner H., Kochulla A.R., et al. Recommendations from the German Respiratory Society for Pulmonary Rehabilitation in Patients with COVID-19 // Pneumologie. 2020. Vol. 74, No. 8. P. 496–504. DOI: 10.1055/a-1193-9315

[41] Ambrose AF, Kurra A, Tsirakidis L, et al. Rehabilitation and In-Hospital Mortality in COVID-19 Patients. J Gerontol — Biol Sci Med Sci. 2022;77(4):e148–e154. DOI: 10.1093/gerona/glab321

[42] Ambrose A.F., Kurra A., Tsirakidis L., et al. Rehabilitation and In-Hospital Mortality in COVID-19 Patients // J Gerontol — Biol Sci Med Sci. 2022. Vol. 77, No. 4. P. e148–e154. DOI: 10.1093/gerona/glab321

[43] Bubnova MG, Shlyakhto EV, Aronov DM, et al. Coronavirus disease 2019: features of comprehensive cardiac and pulmonary rehabilitation. Russian Journal of Cardiology. 2021;26(5):183–222. (In Russ.). DOI: 10.15829/1560-4071-2021-4487

[44] Бубнова М.Г., Шляхто Е.В., Аронов Д.М., и др. Новая коронавирусная инфекционная болезнь COVID-19: особенности комплексной кардиологической и респираторной реабилитации // Российский кардиологический журнал. 2021. Т. 26, № 5. С. 183–222. DOI: 10.15829/1560-4071-2021-4487

[45] Kryukov EV, Trishkin DV, Salukhov VV, et al. A Prospective Multicenter Randomized Study State of Humoral Immunity after a New Coronavirus Infection (COVID-19) of a Mild or Asymptomatic Course. Annals of the Russian academy of medical sciences. 2021;76(4):361–367. (In Russ.). DOI: 10.15690/vramn1582

[46] Крюков Е.В., Тришкин Д.В., Салухов В.В., и др. Особенности формирования и продолжительность сохранения нейтрализующих антител к S-белку SARS-CoV-2 у лиц, перенесших новую коронавирусную инфекцию (COVID-19) легкого или бессимптомного течения // Вестник Российской академии медицинских наук. 2021. Т. 76, № 4. С. 361–367. DOI: 10.15690/vramn1582

[47] Kryukov EV, Salukhov VV, Kotiv BN, et al. Factors affecting the content of Ig G-antibodies to S-protein SARS-CoV-2 in the blood of reconvalescents after new coronaviral infection (COVID-19). Medical Council. 2022;16(4):51–65. (In Russ.). DOI: 10.21518/2079-701X-2022-16-4-51-65

[48] Крюков Е.В., Салухов В.В., Котив Б.Н., и др. Факторы, влияющие на содержание IgG-антител к S-белку SARS-CoV-2 в крови у реконвалесцентов после новой коронавирусной инфекции (COVID-19) // Медицинский совет. 2022. Т. 16, № 4. С. 51–65. DOI: 10.21518/2079-701X-2022-16-4-51-65

[49] Kryukov EV, Arsentev VG, Bulan’kov YuI, et al. Herd immunity to SARS-CoV-2 among adolescent students of the Russian Defense Ministry Colleges of the city of Saint Petersburg. Pediatrics named after G.N. Speransky. 2022;101(5):69–75. (In Russ.). DOI: 10.24110/0031-403X-2022-101-5-69-75

[50] Крюков Е.В., Арсентьев В.Г., Буланьков Ю.И., и др. Результаты изучения коллективного иммунитета к SARS-CoV-2 у подростков, обучающихся в довузовских образовательных организациях Министерства обороны РФ // Педиатрия. Журнал им. Г.Н. Сперанского. 2022. Т. 101, № 5. P. 69–75. DOI: 10.24110/0031-403X-2022-101-5-69-75

[51] Polozhikhina MA. Mortality during the COVID-19 pandemic and risk reduction directions: preliminary results for 2020. Economic and social problems of Russia. 2021;(2):50–73. (In Russ.). DOI: 10.31249/espr/2021.02.03

[52] Положихина М.А. Смертность в период пандемии COVID-19 и направления снижения риска: предварительные итоги 2020 г. // Экономические и социальные проблемы России. 2021. № 2. С. 50–73. DOI: 10.31249/espr/2021.02.03

RIGHTS & PERMISSIONS

Eco-Vector